Tag: Lyndra Therapeutics

Lyndra Therapeutics has filed a notice of an exempt offering of securities to raise $179,262,848.00 in New Equity Investment.

Lyndra Therapeutics has filed a notice of an exempt offering of securities to raise $179,262,848.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Lyndra Therapeutics is raising $179,262,848.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Patricia Hurter played a…

Read More Read More